Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Art of Investing -- Ignore unavailable to you. Want to Upgrade?

To: Rarebird who wrote (3081)	12/23/2021 3:39:49 PM
From: Cogito Ergo Sum	Respond to of 10695

To: Rarebird who wrote (3081)	12/23/2021 3:48:35 PM
From: Sun Tzu	Read Replies (1) \| Respond to of 10695

Google and Apple are probably the two most global companies. Their fortune is tied to the global GDP, which should still do well going forward. I agree on healthcare. For most of 2021 they were killed and now they are showing overperformance. I have had some RXL and ABBV, and am considering RPRX. Many of the genetic companies are also good value and will do well. I am up 30% on my NTLA that I bought just a short while ago. There are others in wing to be bought - some with actual real earnings that are improving well. Some semis, especially in the areas of AI and power semiconductors and automotive could do very well. The logic here is that as the supply chain constraints ease, these guys should do even better than they are doing. Most of them have great looking charts which goes hand in hand with being expensive. Given the outlook for lower growth in H1 and higher interest rates in H2, the timing will be a balancing act and if they don't deliver, they will drop like a rock.

To: Rarebird who wrote (3081)	12/29/2021 7:49:56 PM
From: Sun Tzu	Read Replies (1) \| Respond to of 10695

What in the world happened to KBA today? Although I believe that China is uninvestable for now, the two ETFs you hold would be the ones that I'd pick if I were to invest in China. I've rarely seen an ETF gap down like that. Was there a specific company or sector that dragged it down? Somewhat related - I've been resisting the temptation to buy KURE because I've been expecting that sector to be the next one under regulatory scrutiny. Does anyone know if that is what happened with it today?